Goldman Sachs’s Burning Rock Biotech BNR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,545
| Closed | -$125K | – | 5118 |
|
|
2022
Q4 | $125K | Buy |
+5,545
| New | +$125K | ﹤0.01% | 4624 |
|
|
2022
Q1 | – | Sell |
-4,066
| Closed | -$387K | – | 5750 |
|
|
2021
Q4 | $387K | Sell |
4,066
-4,103
| -50% | -$391K | ﹤0.01% | 4656 |
|
|
2021
Q3 | $1.46M | Buy |
8,169
+651
| +9% | +$116K | ﹤0.01% | 3719 |
|
|
2021
Q2 | $2.22M | Sell |
7,518
-60,996
| -89% | -$18M | ﹤0.01% | 3428 |
|
|
2021
Q1 | $18.4M | Buy |
+68,514
| New | +$18.4M | ﹤0.01% | 1739 |
|
|
2020
Q4 | – | Sell |
-3,394
| Closed | -$851K | – | 4644 |
|
|
2020
Q3 | $851K | Buy |
3,394
+394
| +13% | +$98.8K | ﹤0.01% | 3396 |
|
|
2020
Q2 | $810K | Buy |
+3,000
| New | +$810K | ﹤0.01% | 3351 |
|